ROBERTS 063 (Agrylin 0.5 mg)
Generic Name: anagrelide
Pill with imprint ROBERTS 063 is White, Capsule-shape and has been identified as Agrylin 0.5 mg. It is supplied by Shire US Inc.
Agrylin is used in the treatment of thrombocythemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ROBERTS 063
Agrylin
- Generic Name
- anagrelide
- Imprint
- ROBERTS 063
- Strength
- 0.5 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous coagulation modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Shire US Inc
- National Drug Code (NDC)
- 54092-0063
More about Agrylin (anagrelide)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Generic Availability
- Drug class: miscellaneous coagulation modifiers
- FDA Alerts (2)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.